| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d75d1a4caed60a9316608ed9c231546c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-988
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-90203
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-56 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57446 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-527
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2003-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_027dee744342dc7f1f8001f725812ad1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62cdb8062fcad16bf7ddea8c321fec4e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b542e917e5cebad8a1ec1f22a75dbc00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_786e1ea8ddbee098a1cf2dcd574d4b5d |
| publicationDate |
2004-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2004321102-A |
| titleOfInvention |
Method for detecting metastatic cancer cells derived from gastric cancer |
| abstract |
A novel marker with high specificity is identified for peritoneal dissemination of gastric cancer or detection of free cancer cells in the peritoneal cavity. A step of collecting a biological sample from a subject, a step of detecting the presence of at least one of aldehyde dehydrogenase and dopa decarboxylase from the biological sample of the subject, and the presence of at least one of aldehyde dehydrogenase and dopa decarboxylase In this case, it is determined that there is a high possibility that gastric cancer-derived metastatic cancer cells are contained in the sample. By using these as markers for metastatic cancer cells derived from gastric cancer, the presence or absence of peritoneal metastasis in gastric cancer patients can be detected quickly and reliably, and it is a powerful tool for deciding whether to apply intraperitoneal cancer chemotherapy. Material is provided. [Selection diagram] None |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016143697-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2016143697-A1 |
| priorityDate |
2003-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |